Rh Antigen ABO Grouping Gel Card Method

Product description

The combination of Microcolumn Gel Card ‘s molecular sieve technology and immunological technology,have high sensitivity, good repeatability and accurate results.Now,Microcolumn Gel Card technology is the most advanced detection technology for blood transfusion detection. This method has become a routine clinical detection technology of erythrocyte blood group serology in developed countries, and the same in China.

Advantages:

• High sensitivity,better than others
• Sample use less blood
• Card can keep for days,image can keep permanently
• Result easy to judge

• Quantitative analysis,good repeatability
• Simple operation ,Standardization,Automation

Principle

Company profile

Aikang Group is a national high-tech enterprise specialized in R&D, production, sales and service of medical devices. Founded in 2003, Aikang is headquartered in Shenzhen China and has established three R&D and production bases with a total area of 30,000 sqm and hundreds of employees.

The mission of Aikang is not only for China, but also for the world,and the vision is to be the leader in global medical automation.

Aikang is always focusing on innovation and quality, constantly communicating with partners from Germany, Switzerland etc., and insisting on developing products under international standards with its own intellectual properties. Every year, over 10% of sales revenue is invested in R&D. By 2020, Aikang has achieved 187 patents applied and certificates of ISO, CE etc.

Innovation Achievement

9 product series

100+ NMPA certificates

400+ intellectual property